Date Filed | Type | Description |
10/04/2023 |
4
| Febbo Phillip G. (Chief Scientific & Med Officer) has filed a Form 4 on VERACYTE, INC.
Txns:
| Granted 53,182 shares
@ $0 Granted 85,858 options to buy
@ $21.96, valued at
$1.9M
|
|
10/04/2023 |
3
| Febbo Phillip G. (Chief Scientific & Med Officer) has filed a Form 3 on VERACYTE, INC. |
08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/08/2023 |
8-K
| Quarterly results |
07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/09/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
06/09/2023 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 10% stake in VERACYTE, INC. |
06/08/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/08/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/08/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/08/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/08/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/08/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/08/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/08/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/08/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/08/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/06/2023 |
4
| Wygant Jonathan (VP, Chief Accounting Officer) has filed a Form 4 on VERACYTE, INC.
Txns:
| Paid exercise price by delivering 260 shares
@ $26.72, valued at
$6.9k
|
|
06/06/2023 |
4
| Chambers Rebecca (CFO) has filed a Form 4 on VERACYTE, INC.
Txns:
| Paid exercise price by delivering 1,183 shares
@ $26.72, valued at
$31.6k
|
|
06/06/2023 |
4
| Stapley Marc (CEO) has filed a Form 4 on VERACYTE, INC.
Txns:
| Paid exercise price by delivering 3,203 shares
@ $26.72, valued at
$85.6k
|
|
06/06/2023 |
4
| Anderson Bonnie H (Director) has filed a Form 4 on VERACYTE, INC.
Txns:
| Paid exercise price by delivering 1,304 shares
@ $26.72, valued at
$34.8k
|
|
06/06/2023 |
4
| McGuire Annie (SVP, General Counsel) has filed a Form 4 on VERACYTE, INC.
Txns:
| Paid exercise price by delivering 494 shares
@ $26.72, valued at
$13.2k
|
|
06/01/2023 |
4
| Bhanji Muna (Director) has filed a Form 4 on VERACYTE, INC.
Txns:
| Sold 1,539 shares
@ $25.91, valued at
$39.9k
|
|
06/01/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
05/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
|